title: I-123-Metaiodobenzylguanidine imaging in patients with atrial fibrillation undergoing cardiac mapping and ablation of autonomic ganglia.
authors.affiliation: Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: rlemery@ottawaheart.ca.
authors.forename: Robert
authors.initials: R
authors.lastname: Lemery
authors.affiliation: Hobart Healthcare, London, United Kingdom.
authors.forename: Shlomo
authors.initials: S
authors.lastname: Ben-Haim
authors.affiliation: Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
authors.forename: Glenn
authors.initials: G
authors.lastname: Wells
authors.affiliation: Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
authors.forename: Terrence D
authors.initials: TD
authors.lastname: Ruddy
mesh_terms: D019797:3-Iodobenzylguanidine / Q000494:pharmacology*; D000368:Aged; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery; D018780:Body Surface Potential Mapping / Q000379:methods*; D017115:Catheter Ablation / Q000379:methods*; D005260:Female; D005725:Ganglia, Autonomic / Q000503:physiopathology*; D006325:Heart Atria / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D019275:Radiopharmaceuticals / Q000494:pharmacology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine